AbbVie
ABBV
ABBV
3,805 hedge funds and large institutions have $265B invested in AbbVie in 2025 Q1 according to their latest regulatory filings, with 262 funds opening new positions, 1,489 increasing their positions, 1,618 reducing their positions, and 125 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 3,732 → 3,805 (+73)
0.88% less ownership
Funds ownership: 72.25% → 71.37% (-0.88%)
8% less repeat investments, than reductions
Existing positions increased: 1,489 | Existing positions reduced: 1,618
Holders
3,805
Holding in Top 10
246
Calls
$3.94B
Puts
$3.43B
Top Buyers
| 1 | +$1.08B | |
| 2 | +$747M | |
| 3 | +$582M | |
| 4 |
Goldman Sachs
New York
|
+$555M |
| 5 |
Barclays
London,
United Kingdom
|
+$531M |
Top Sellers
| 1 | -$1.55B | |
| 2 | -$583M | |
| 3 | -$422M | |
| 4 |
Amundi
Paris,
France
|
-$328M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$260M |